Company
AnaCardio
- Business model
- B2B
Record updated 28 September 2026
About
AnaCardio is a clinical stage company developing novel drugs to treat heart failure. The company was founded based on ground-breaking research from Karolinska Institute (Sweden) showing improved contractility of the heart muscle through a unique and differentiated mechanism.